Simpson Bruce W 4
4 · HI TECH PHARMACAL CO INC · Filed Jul 16, 2012
Insider Transaction Report
Form 4
Simpson Bruce W
Director
Transactions
- Exercise/Conversion
Common Stock
2012-07-12$9.65/sh+6,187$59,705→ 9,281 total - Exercise/Conversion
Stock Option (Right to Buy)
2012-07-12−6,188→ 3,093 totalExercise: $5.83From: 2009-11-13Exp: 2018-11-13→ Common Stock (6,188 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2012-07-13−1,907→ 5,000 totalExercise: $19.59From: 2010-11-12Exp: 2019-11-12→ Common Stock (1,907 underlying) - Exercise/Conversion
Common Stock
2012-07-13$19.59/sh+1,907$37,358→ 1,907 total - Exercise/Conversion
Stock Option (Right to Buy)
2012-07-12−3,094→ 0 totalExercise: $14.99From: 2007-11-09Exp: 2016-11-09→ Common Stock (3,094 underlying) - Sale
Common Stock
2012-07-13$29.33/sh−1,907$55,932→ 0 total - Exercise/Conversion
Common Stock
2012-07-12$5.83/sh+6,188$36,076→ 15,469 total - Exercise/Conversion
Common Stock
2012-07-12$19.59/sh+3,093$60,592→ 18,562 total - Exercise/Conversion
Stock Option (Right to Buy)
2012-07-12−3,093→ 6,907 totalExercise: $19.59From: 2010-11-12Exp: 2019-11-12→ Common Stock (3,093 underlying) - Exercise/Conversion
Common Stock
2012-07-12$14.99/sh+3,094$46,379→ 3,094 total - Sale
Common Stock
2012-07-12$27.75/sh−18,562$515,096→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2012-07-12−6,187→ 0 totalExercise: $9.65From: 2008-11-15Exp: 2017-11-15→ CommonStock (6,187 underlying)
Footnotes (5)
- [F1]The price reported in this column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.35 to $28.05, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., shares, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in this column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.24 to $29.48, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., shares, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Option granted under Hi-Tech Pharmacal Co., Inc.'s 1994 Directors Stock Option Plan.
- [F4]The option became (or becomes) exercisable in four equal annual installments beginning on the first anniversary of the grant date.
- [F5]Other than the options to acquire an aggregate of 8,093 shares reflected on this form as still held by the filer, the filer is also the holder of additional options to acquire 22,375 shares of Hi-Tech Pharmacal Co., Inc. common stock (for total options to acquire an aggregate of 30,468 shares currently held by the filer) which options were granted on various dates, with various exercise prices, exercise dates and expiration dates.